|
Q3 2024
|
31 |
91,786 |
DBD, ENDO INC Common, GSM, PL
|
13F-HR
|
11/12/2024 |
000089843224000895 |
|
Q2 2024
|
37 |
87,412 |
DBD, ENDO INC Common, GSM, HLF
|
13F-HR
|
8/6/2024 |
000089843224000655 |
|
Q1 2024
|
38 |
63,362 |
DBD, CNDA, GSM, PL
|
13F-HR
|
5/8/2024 |
000089843224000378 |
|
Q4 2023
|
44 |
96,716 |
DBD, HENNESSY CAPITAL INVST CORP, CNDA, XPDB
|
13F-HR
|
2/1/2024 |
000089843224000070 |
|
Q3 2023
|
55 |
84,722 |
HENNESSY CAPITAL INVST CORP, DBD, WESCO INTERL 1000 DS RP 1 SRS A PRF (NYS), CNDA
|
13F-HR
|
11/7/2023 |
000089843223000768 |
|
Q2 2023
|
57 |
29,915 |
HENNESSY CAPITAL INVST CORP, CNDA, XPDB, ZING
|
13F-HR
|
8/1/2023 |
000089843223000553 |
|
Q1 2023
|
108 |
71,760 |
KVSC, HENNESSY CAPITAL INVST CORP, VLAT, TCVA
|
13F-HR
|
5/12/2023 |
000089843223000298 |
|
Q4 2022
|
165 |
183,189 |
DGNU, KVSC, VLAT, WPCB
|
13F-HR
|
2/9/2023 |
000089843223000065 |
|
Q3 2022
|
257 |
329,356 |
OSI, REVH, DGNU, LCA
|
13F-HR
|
11/9/2022 |
000156761922019341 |
|
Q2 2022
|
282 |
395,889 |
OSI, REVH, DGNU, LCA
|
13F-HR
|
8/9/2022 |
000156761922015209 |
|
Q1 2022
|
330 |
658,201 |
HENNESSY CAPITAL INVST CORP, OSI, REVH, VLAT
|
13F-HR
|
5/13/2022 |
000156761922010408 |
|
Q4 2021
|
377 |
1,086,408 |
NSTB, HCVIU, CNDA/U, REVH
|
13F-HR
|
2/14/2022 |
000156761922004024 |
|
Q3 2021
|
403 |
1,266,438 |
NSTB, REVH, HCVIU, IQIYI INC
|
13F-HR
|
11/12/2021 |
000156761921020054 |
|
Q2 2021
|
399 |
1,206,600 |
IQIYI INC, NSTB, OSI/U, REVHU
|
13F-HR
|
8/11/2021 |
000156761921015080 |
|
Q1 2021
|
221 |
1,008,739 |
REVHU, NSTB, DGNU, PDAC
|
13F-HR
|
5/25/2021 |
000156761921011158 |
|
Q4 2020
|
85 |
626,932 |
TEVA PHARMACEUTICAL FIN LLC, PDAC, APSG/U, SCOAU
|
13F-HR
|
5/25/2021 |
000156761921011156 |